If you're interested, here's some of my research....
(but obviously, it is related more to be and my infections and conditions)
EBV
Intermediate filament IF - Keratin, and Vimentin (57kDA) (part of nuclear envelope)
p542 antibodies
p554 antibodies
dsDNA (anti-double stranded DNA) (antinuclear antibody)
Anti-cyclic citrullinated peptide (CCP) (seen in rheumatoid arthritis)
Thyrotropin receptor antibodies (TRAbs) (seen in Graves disease and hyperthyroidism)
NMDA receptor (N-methyl-D-aspartate receptor) (can cause autonomic dysfunction)
Myelin basic protein (MBP)
Smooth Muscle
Cardiolipin
Annexin V
Anti-protein S
Prothrombin
Histone (antinuclear antibody)
Anti-Sm (Smith) – (an antinuclear antibody)
Anti-Ro/SSA – (antinuclear antibody)
Anti-La/SSB
β2 glycoprotein
Platelet membrane glycoprotein IIb
Alpha-synuclein
Strep
Myocardial autoantibodies
Protein Disulfide Isomerase (PDI) autoantibodies
Myosin
β2-glycoprotein I antibody (β2GPI) – (involved in antiphospholipid syndrome)
CFS
Human dUTPase
ANA
Intermediate filament IF - Lamin B1, and cytoplasmic proteins (part of nuclear envelope)
68/48 kDa protein (68 kda = HSP70)
dsDNA (anti-double stranded DNA)
Phospholipids
Cardiolipin aCL (an anti-mitochondrial antibody, and Phospholipid)
Phosphatidylinositol (PI) – (type of Phospholipid)
Gangliosides (AGA)
5-HT
Neoepitopes
Palmitic acid (fatty acid)
Myristic acid (fatty acid)
Oleic acid (fatty acid)
NO-phenylalanine
NO-Bovine serum albumin (nitro-BSA)
M1/3/4 (AChR)
Beta-2 Adr
TPO
Antineutrophil cytoplasmic antibodies (ANCA)
Mu-opioid receptor
Microtubule-associated protein 2 (MAP2)
ssDNA
HSP60 (Chlamydia pneumoniae peptide)
Malondialdehyde MDA (by-product of lipid peroxidation)
Azelaic acid (by-product of lipid peroxidation)
S-farnesyl-L-cysteine
N-oxide modified amino-acids (nitro-tyrosine, nitro-phenylalanine, nitro-arginine, nitro-tryptophan, and nitro-cysteinyl)
Oxidized LDL (oxLDL) antibodies
Antiendothelial cell antibodies
Antineuronal cell antibodies
Lipopolysaccharides
Anti-Sa (Vimentin) (62 kDa)
Parvovirus
Collagen II
Intermediate filament IF – Keratin (part of nuclear envelope)
Angiotensin II type 1 (AT1) receptor
Myelin basic protein
Cardiolipin aCL (an anti-mitochondrial antibody, and Phospholipid)
Platelet membrane glycoprotein llb/lla
dsDNA antibody (anti-double stranded DNA)
ssDNA
Anti-lymphocyte antibody
Rheumatoid factor
ANA
Anti-mitochondrial antibody (AMA)
Anti-smooth muscle antibody (ASMA) (actin, troponin, and tropomyosin)
Anti-parietal cell antibody (Gastric Parietal Cell Antibodies, GPA)
Anti-reticulin antibody (ARA)
Phosphatidylserine (PS) – (a type of Phospholipid)
β2-glycoprotein I antibody (β2GPI) – (involved in antiphospholipid syndrome)
Anti-GAD glutamic acid decarboxylase (islet cells)
Thyrotropin receptor antibodies (TRAbs)
Anti-cyclic citrullinated peptide (CCP)
Enterovirus
Coxsackie 3: Myosin
Coxsackie 3: Adenine nucleotide translocator (ANT) antibodies
Coxsackie 3: Anti-flavoprotein antibodies
Coxsackie 3: Actin (Anti-smooth muscle antibody)
Coxsackie 3: Tropomyosin (Anti-smooth muscle antibody)
Coxsackie 3: Heat shock proteins
Coxsackie 3: Desmin
Beta-cell autoantibodies (aka islet cell)
Mycoplasma Pneumoniae
GALC
Sleep Apnea
Oxidized LDL (low-density lipoprotein, OxLDL) antibodies
Anti-IgLON5
Anti-Coatomer Protein Complex Subunit Epsilon (COPE) Autoantibodies
Neuroblastoma suppressor of tumorigenicity 1 (NBL1-Abs)
Phospholipids
Chlamydia Pneumoniae
HSP60 (Chlamydia pneumoniae peptide)
Rheumatoid Factor
Hashimoto’s
Rheumatoid factor (RF)
HSP60 elevated in blood
Cardiolipin
β2-glycoprotein I
Guttate Psoriasis
dsDNA
HSP60Sp (Streptococcus pyogenes)
HSP60 elevated in blood
Psoriasis
High-density lipoproteins (HDL)
apolipoprotein A-I
Apolipoprotein E
HSV-2
ANA (6 of 38?)
unclassified neural antibodies (4 of 38)
Autonomic Dysfunction
Ganglionic (alpha 3) acetylcholine receptors (gAChRs)
Autonomic nerve autoantibodies (ANabs)
Autoimmune Dysautonomia (Mayo Clinic Panel)
Acetylcholine Receptor (Muscle AChR) Binding
Ganglionic (alpha 3) acetylcholine receptors (gAChRs)
Antineuronal Nuclear Antibody, Type 1 (ANNA-1 or Anti-Hu)
Antineuronal Nuclear Antibody, Type 2 (ANNA-2 or Anti-Ri)
Dipeptidyl peptidase-like protein 6 (DPPX Receptor)
Glutamic Acid Decarboxylase (GAD65)
VGKC (voltage gated potassium channel)
VGCC-N-Type (N-Type Voltage-gated calcium-channel)
VGCC-P/Q-Type (P/Q-Type Voltage-gated calcium-channel)
Striational Antibodies (Striated Muscle) CPT 86255
Amphiphysin CPT 84182
CASPR2 (Contactin-Associated Protein-2)
Collapsin Response-Mediator Protein-5 (CRMP-5)
GABABR (gamma-aminobutyric acid B receptor)
LGI1 (Leucine-Rich, Glioma-Inactivated Protein 1)
NMDA (N-methyl-D-Aspartate Receptor)
Purkinje cell cytoplasmic antibody, type Tr (PCA-Tr)
Purkinje cell cytoplasmic antibody, type 1 (PCA-1)
Purkinje cell cytoplasmic antibody, type 2 (PCA-2)
Orthostatic Hypotension
Monoclonal autoantibody (C5F2)
Ganglionic (alpha 3) nicotinic acetylcholine receptor
G-ACh receptors
β 2 adrenergic receptors
M2 muscarinic receptors
Bright’s Disease (lupus nephritis, Glomerulonephritis, acute nephritis)
Abdominal Muscle Spasm
Serositis (Sm Smith, dsDNA)
Acquired neuromyotonia (voltage-gated potassium channels, Caspr2, voltage-gated potassium channel)
Myocarditis (mitochondrial M7, alpha myosin, ANT)
Autoimmune atrophic gastritis (parietal cell and anti–intrinsic factor (IF)
Myositis (Anti-Ro/SSA, anti-ARS)
Mixed connective tissue disease (MCTD) (U1-ribonucleoprotein RNP)
Polymyositis (Anti-PM/Scl)
Autoimmune myositis
Necrotizing autoimmune myopathy (anti-signal recognition particle anti-SRP, HMGCR (3-hydroxy-3-methylglutaryl-coenzyme A reductase)
Anti-synthetase antibody syndrome (Jo-1, PL-7 and anti-PL-12, anti-EJ, anti-OJ, anti-KS, anti-Zo, and anti-Ha)
Studies
(1986) A study of anti-group A streptococcal monoclonal antibodies cross-reactive with myosin
(1987) Cardiac myosin induces myocarditis in genetically predisposed mice
- Coxsackie 3: Myosin antibodies
(1989) Anti-DNA and antilymphocyte antibodies during acute infection with human parvovirus B19
- Parvovirus B19: Anti-dsDNA antibody, Anti-ssDNA antibody, Cytotoxic anti-lymphocyte antibody
(1989) Antibodies to platelet membrane glycoprotein antigens in three cases of infectious mononucleosis‐induced thrombocytopenic purpura
- EBV: Platelet membrane glycoprotein IIb
(1992) Age-related interference with Chlamydia pneumoniae microimmunofluorescence serology due to circulating rheumatoid factor.
- Chlamydia Pneumoniae: Rheumatoid Factor
(1994) Chronic fatigue syndrome: immune dysfunction, role of pathogens and toxic agents and neurological and cardial changes
- CFS: ANA, microsomal thyroid antibodies (TPO)
(1994) Epstein-Barr virus-transformed human B lymphocytes produce natural antibodies to histones
(1995) High incidence of antibodies to 5-hydroxytryptamine, gangliosides and phospholipids in patients with chronic fatigue and fibromyalgia syndrome and their relatives: evidence for a clinical entity of both disorders
- 5-HT
- Gangliosides
- Phospholipids
(1995) Platelet Membrane Glycoprotein IIb/IIIa has Sequence Homologies with Human Virus Proteins and Synthetic Viral Peptides Inhibit Anti-GPIIb/IIIa Antibodies in Autoimmune Thrombocytopenic Purpura
- Parvovirus B19: Platelet membrane glycoprotein IIb/IIIa
(1996) Autoantibodies following Parvovirus B19 infection
- Parvovirus B19: Rheumatoid factor, ANA, Anti-mitochondrial antibody, Anti-smooth muscle antibody, Anti-gastric parietal cell antibody, Anti-reticulin antibody
(1996) High expression of heat shock protein 60 in follicular cells of Hashimoto's thyroiditis
(1996) Autoantibodies to nuclear envelope antigens in chronic fatigue syndrome
- ANA
- Nuclear envelope antigens
- lamin B1 protein
(1997) High frequency of autoantibodies to insoluble cellular antigens in patients with chronic fatigue syndrome
- Antineutrophil cytoplasmic antibodies (ANCA)
(1997) Similarities of specificity and cofactor dependence in serum antiphospholipid antibodies from patients with human parvovirus B19 infection and from those with systemic lupus erythematosus
- Parvovirus B19: Phosphatidylserine (10 of 12), Cardiolipin (6 of 12)
(1998) Chronic parvovirus B19 infection induces the production of anti-virus antibodies with autoantigen binding properties
- Parvovirus B19: Collagen II, Keratin, ssDNA, Cardiolipin
(1999) Characterization of anti-heart antibodies in mice after infection with coxsackie B3 virus
- Coxsackie 3: anti-myosin heavy chain, anti-actin, and anti-tropomyosin antibodies, heat shock proteins, and desmin
(1999) Disturbance of myocardial energy metabolism in experimental virus myocarditis by antibodies against the adenine nucleotide translocator
- Coxsackie 3: adenine nucleotide translocator antibodies
(1999) Parvovirus B19‐associated interstitial lung disease, hepatitis, and myositis
- Parvovirus B19: Homogenous nucleolar ANA 1:160 Anti-SS-A
(1999) Autoantibodies against oxidised low-density lipoprotein in patients with obstructive sleep apnoea.
- Sleep Apnea: oxidised low-density lipoprotein (OxLDL-Abs)
(2000) Coxsackievirus B3 infection induces anti-flavoprotein antibodies in mice
- Coxsackie 3: anti-flavoprotein antibodies
(2000) Specificity of anti-phospholipid antibodies in infectious mononucleosis: a role for anti-cofactor protein antibodies
- EBV: Cardiolipin (14 of 46, 30%), annexin V (26%), Anti-protein S (10 of 46 22%), prothrombin (3 of 46 6.5%)
(2001) Autoantibodies to a 68/48 kDa protein in chronic fatigue syndrome and primary fibromyalgia: a possible marker for hypersomnia and cognitive disorders
(2001) Pericardial Effusion and Cardiomyopathy Following Arthritis with Parvovirus B19 Infection: Response to Intravenous Immunoglobulin
- Parvovirus B19: Transient ANA
(2001) Antibodies to beta 2-glycoprotein I and cardiolipin with symptoms suggestive of systemic lupus erythematosus in parvovirus B19 infection
- Parvovirus B19: Anti-cardiolipin antibody
(2002) Chronic fatigue syndrome and arthralgia following parvovirus B19 infection
(2002) Absence of elevated anti–α-synuclein and anti-EBV latent membrane protein antibodies in PD
(2003) Autoantibodies against muscarinic cholinergic receptor in chronic fatigue syndrome
- M1 receptor
- Mu-opioid receptor
- ANA
(2003) Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection
- Parvovirus B19: Anti-phosphatidylserine antibody, Anti-β2-glycoprotein I antibody, Anti-cardiolipin antibody
(2003) Enterovirus infections are associated with the induction of beta-cell autoimmunity in a prospective birth cohort study
- Enterovirus: beta-cell autoantibodies (aka islet cell)
(2004) Expression of the Epstein-Barr virus nuclear antigen-1 (EBNA-1) in the mouse can elicit the production of anti-dsDNA and anti-Sm antibodies
- EBV: anti-dsDNA and anti-Sm antibodies
(2004) S. pyogenes heat-shock protein associated with chronic psoriasis
- Guttate psoriasis: HSP60Sp (Streptococcus pyogenes)
(2004) Antiphospholipid Syndrome Infectious Origin
- Have to authenticate, but… says that Antiphospholipid Syndrome (APS) is associated w/ EBV, Parvovirus B19, Streptococcus
- EBV: Cardiolipin, β2GPI, Phospholipid, and Thrombosis
- Parvovirus B19: Cardiolipin, β2GPI, Phospholipid, and Thrombosis
- Streptococcus: Cardiolipin, Phospholipid
(2005) Rheumatoid arthritis, type 1 diabetes, and Graves' disease after acute parvovirus B19 infection
- Parvovirus B19: Rheumatoid factor Anti-GAD, high level Anti-TSH
(2005) Effects of Repeated Chlamydia pneumoniae Inoculations on Aortic Lipid Accumulation and Inflammatory Response in C57BL/6J Mice
- Chlamydia Pneumoniae: chlamydial heat shock protein 60 (Hsp60) immunoglobulin G2c subclass antibodies
(2005) Evaluation of autoantibodies to common and neuronal cell antigens in Chronic Fatigue Syndrome
- CFS: antibodies to microtubule-associated protein 2 (MAP2) and ssDNA
(2005) Autoantibodies to Autonomic Nerves Associated With Cardiac and Peripheral Autonomic Neuropathy
- Autonomic Dysfunction: autonomic nerve autoantibodies (ANabs)
(2006) Chronic fatigue syndrome is accompanied by an IgM-related immune response directed against neopitopes formed by oxidative or nitrosative damage to lipids and proteins
- CFS: Antibodies to fatty acids (oleic, palmitic and myristic acid), by-products of lipid peroxidation (MDA, azelaic acid), S-farnesyl-L-cysteine, and N-oxide modified amino-acids (nitro-tyrosine, nitro-phenylalanine, nitro-arginine, nitro-tryptophan, and nitro-cysteinyl)
(2006) Autoantibody Reaction to Myelin Basic Protein by Plasma Parvovirus B19 IgG in MS Patients
- Parvovirus B19: Myelin basic protein
(2007) Antiphospholipid Antibodies in Response to Infection
- Have to verify this… but says Antiphospholipid Syndrome (APS) is associated with Parvovirus B19, EBV, Streptococcus, and Chlamydia
- Parvovirus B19: Cardiolipin, anti–β2 -GPI, LA (Lupus Coagulant), and Thrombosis
- EBV: Cardiolipin, anti–β2 -GPI, LA (Lupus Coagulant), and Thrombosis
- Streptococcus: Cardiolipin, anti–β2 -GPI, LA (Lupus Coagulant), and Thrombosis
- Chlamydia: Cardiolipin, anti–β2 -GPI
(2007) Increased serum IgM antibodies directed against phosphatidyl inositol (Pi) in chronic fatigue syndrome (CFS) and major depression: evidence that an IgM-mediated immune response against Pi is one factor underpinning the comorbidity between both CFS and depression
- CFS: Phosphatidylinositol (PI)
(2008) Acute phase phospholipids related to the cardiolipin of mitochondria in the sera of patients with chronic fatigue syndrome (CFS), chronic ciguatera fish poisoning (CCFP), and other diseases attributed to chemicals, Gulf War, and marine toxins
(2008) An IgM-mediated immune response directed against nitro-bovine serum albumin (nitro-BSA) in chronic fatigue syndrome (CFS) and major depression: evidence that nitrosative stress is another factor underpinning the comorbidity between major depression and CFS
- CFS: NO-Bovine serum albumin (nitro-BSA) (a neoepitope of BSA formed by damage caused by nitrosative stress)
(2009) Anticardiolipin antibodies in the sera of patients with diagnosed chronic fatigue syndrome
(2009) Prevalence of Agonistic Autoantibodies Against the Angiotensin II Type 1 Receptor and Soluble fms-Like Tyrosine Kinase 1 in a Gestational Age–Matched Case Study
- Parvovirus B19: Angiotensin II type 1 receptor
(2009) Persistent parvovirus B19 infection detected by specific CD4+ T‐cell responses in a patient with hepatitis and polyarthritis
- Parvovirus B19: Anti-cyclic citrullinated peptide antibody
(2009) Anti-human parvovirus B19 nonstructural protein antibodies in patients with rheumatoid arthritis
- Parvovirus B19: Anti-cyclic citrullinated peptide antibody
(2009) Autoantibodies, Polymorphisms in the Serotonin Pathway, and Human Leukocyte Antigen Class II Alleles in Chronic Fatigue Syndrome
- CFS: antiendothelial (30%, 24/81) and antineuronal (16%, 13/81) cell antibodies
(2010) Post-Streptococcal Auto-Antibodies Inhibit Protein Disulfide Isomerase and Are Associated with Insulin Resistance
- Streptococcus: Protein Disulfide Isomerase (PDI) auto-antibodies
(2010) Prevalence of Autoantibodies in Patients of Psoriasis
(2011) Severe glomerulonephritis and encephalopathy associated with parvovirus B19 infection mimicking systemic lupus erythematosus
- Parvovirus B19: Nucleolar ANA 1:400 Anti-dsDNA ≥1:320 Anti-cardiolipin IgM
(2011) Increased plasma peroxides as a marker of oxidative stress in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)
- CFS: oxidized LDL (oxLDL) antibodies
(2011) Induction of anti‐β2‐glycoprotein I autoantibodies in mice by protein H of Streptococcus pyogenes
- Streptococcus: β2‐glycoprotein I
(2012) IgM-mediated autoimmune responses directed against anchorage epitopes are greater in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) than in major depression
- CFS: anchorage molecules (palmitic and myristic acid and S-farnesyl-L-cysteine), and NO-phenylalanine
(2012) Fibromyalgia and chronic fatigue syndrome in children
(2013) Implications of a Vasodilatory Human Monoclonal Autoantibody in Postural Hypotension
- Orthostatic hypotension: monoclonal autoantibody (C5F2)
(2013) Epitopes of microbial and human heat shock protein 60 and their recognition in myalgic encephalomyelitis
- HSP60 (Chlamydia pneumoniae peptide)
(2013) Antiphospholipid antibodies during infectious mononucleosis and their long term clinical significance
(2013) In myalgic encephalomyelitis/chronic fatigue syndrome, increased autoimmune activity against 5-HT is associated with immuno-inflammatory pathways and bacterial translocation
- CFS: 5-HT, ME/CFS (61.5%), “chronic fatigue” CF (13.9%), controls (5.7%), increased IgA antibodies to Lipopolysaccharides
(2014) A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study
(2015) Autoimmune autonomic ganglionopathy manifesting as acute-onset orthostatic hypotension in a patient undergoing peritoneal dialysis
- Orthostatic Hypotension: ganglionic (alpha 3) nicotinic acetylcholine receptor
(2015) Cardiovascular Antibodies and Orthostatic Hypotension
- Orthostatic Hypotension: G-ACh receptors, β 2 adrenergic receptors, and M2 muscarinic receptors
(2016) Antibodies to β adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome
- β-2 adrenergic receptor
- M3 and M4 receptor
(2016) CSF herpes virus and autoantibody profiles in the evaluation of encephalitis
- HSV-2: ANA (6 of 38?), unclassified neural antibodies (4 of 38)
- EBV: Smooth muscle (3 of 6), ANA (2 of 6), unclassified neural antibodies (2 of 6), NMDA receptor (1 of 6) <<< prob more significant than it sounds
(2017) Autoantibody against NBL1 in obstructive sleep apnea patients with cardiovascular disease
- Sleep Apnea: neuroblastoma suppressor of tumorigenicity 1 antibodies (NBL1-Abs)
(2017) Circulating Anti-Coatomer Protein Complex Subunit Epsilon (COPE) Autoantibodies as a Potential Biomarker for Cardiovascular and Cerebrovascular Events in Patients with Obstructive Sleep Apnea
- Sleep Apnea: Anti-Coatomer Protein Complex Subunit Epsilon (COPE) Autoantibodies
(2017) Myalgic encephalomyelitis/chronic fatigue syndrome and gulf war illness patients exhibit increased humoral responses to the herpesviruses‐encoded dUTPase: Implications in disease pathophysiology
(2017) A Retrospective Study on the Association between Thyroid Autoantibodies with β2-glycoprotein and Cardiolipin Antibodies in Recurrent Miscarriage
- Hashimoto: Cardiolipin, and β2-glycoprotein I
(2017) The interaction between anti-Ro/SSA and anti-La/SSB autoantibodies and anti-infectious antibodies in a wide spectrum of auto-immune diseases: Another angle of the autoimmune mosaic
- EBV: Anti-SSA/Ro, Anti-La/SSB
(2018) Circulating autoantibodies against neuroblastoma suppressor of tumorigenicity 1 (NBL1): A potential biomarker for coronary artery disease in patients with obstructive sleep apnea
- Sleep Apnea: neuroblastoma suppressor of tumorigenicity 1 (NBL1-Abs)
(2018) Rheumatic Disease Autoantibodies in Patients with Autoimmune Thyroid Diseases
- Hashimoto: Rheumatoid factor (RF)
(2018) Sleep disorders in primary antiphospholipid syndrome
- Sleep Apnea: Antiphospholipid antibodies (those w/ PAPS had worse sleep than controls)
(2019) Anti-N-methyl-d-aspartate receptor encephalitis associated with reactivated Epstein–Barr virus infection in pediatric patients
- EBV: Anti-N-methyl-d-aspartate receptor (NMDAR) antibodies found in (3) active EBV patients
(2020) Ganglionic Acetylcholine Receptor Antibodies and Autonomic Dysfunction in Autoimmune Rheumatic Diseases
- Autonomic Dysfunction: ganglionic acetylcholine receptors (gAChRs)